Renal insufficiency coexisting with heart failure is related to elevated sympathetic nerve activity

Autonomic Neuroscience: Basic and Clinical

Volumn 155, Issue 1-2, 2010, Pages 104-108

  Oda, Yoshitaka ^a   Joho, Shuji ^a   Harada, Daisuke ^a   Hirai, Tadakazu ^a   Asanoi, Hidetsugu ^b   Inoue, Hiroshi ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b Imizu City Hospital   (Japan)

Author keywords

Heart failure; Kidney; Nervous system; Sympathetic

Indexed keywords

FUROSEMIDE; LOOP DIURETIC AGENT;

ADULT; AGE; AGED; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GLOMERULUS FILTRATION RATE; HEART EJECTION FRACTION; HEART FAILURE; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MUSCLE INNERVATION; NERVE CONDUCTION; PRIORITY JOURNAL; SYMPATHETIC NERVE; SYMPATHETIC TONE;

AGED; FEMALE; GLOMERULAR FILTRATION RATE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; RENAL INSUFFICIENCY; SYMPATHETIC NERVOUS SYSTEM;

EID: 77952543929     PISSN: 15660702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autneu.2010.01.005     Document Type: Article

References (28)

1. Barretto A.C., Santos A.C., Munhoz R., Rondon M.U., Franco F.G., Trombetta I.C., Roveda F., de Matos L.N., Braga A.M., Middlekauff H.R., and Negrão C.E. Increased muscle sympathetic nerve activity predicts mortality in heart failure patients. Int. J. Cardiol. 135 (2009) 302-307
2. Converse Jr. R.L., Jacobsen T.N., Toto R.D., Jost C.M., Cosentino F., Fouad-Tarazi F., and Victor R.G. Sympathetic overactivity in patients with chronic renal failure. N. Engl. J. Med. 327 (1992) 1912-1918
3. Despas F., Detis N., Dumonteil N., Labrunee M., Bellon B., Franchitto N., Galinier M., Senard J.M., and Pathak A. Excessive sympathetic activation in heart failure with chronic renal failure: role of chemoreflex activation. J. Hypertens. 27 (2009) 1849-1854
4. Faber F.E., and Brody M.J. Afferent renal nerve-dependent hypertension following acute renal artery stenosis in the conscious rat. Circ. Res. 57 (1985) 676-688
5. Foundation N.K. K/DOQI, clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Part 4. Definition of and classification of stages of chronic kidney disease. Am. J. Kidney Dis. 39 (2002) S46-S75
6. Gomes M.E., Lenders J.W., Bellersen L., Verheugt F.W., Smits P., and Tack C.J. Sympathoinhibitory effect of statins in chronic heart failure. Clin. Auton. Res. (2009) Electronic publication
7. Goso Y., Asanoi H., Ishise H., Kameyama T., Hirai T., Nozawa T., Takashima S., Umeno K., and Inoue H. Respiratory modulation of muscle sympathetic nerve activity in patients with chronic heart failure. Circulation 104 (2001) 418-423
8. Grassi G., Cattaneo B.M., Seravalle G., Lanfranchi A., Pozzi M., Morganti A., Carugo S., and Mancia G. Effects of chronic ACE inhibition on sympathetic nerve traffic and baroreflex control of circulation in heart failure. Circulation 96 (1997) 1173-1179
9. Grassi G., Seravalle G., Bertinieri G., and Mancia G. Behaviour of the adrenergic cardiovascular drive in atrial fibrillation and cardiac arrhythmias. Acta Physiol. Scand. 177 (2003) 399-404
10. Hainsworth R. Reflexes from the heart. Physiol. Rev. 71 (1991) 617-658
11. Hausberg M., and Grassi G. Mechanisms of sympathetic overactivity in patients with chronic renal failure: a role for chemoreflex activation?. J. Hypertens. 25 (2007) 47-49
12. Hausberg M., Kosch M., Harmelink P., Barenbrock M., Hohage H., Kisters K., Dietl K.H., and Rahn K.H. Sympathetic nerve activity in end-stage renal disease. Circulation 106 (2002) 1974-1979
13. Heistad D.D., Abboud F.M., Mark A.L., and Schmid P.G. Interaction of baroreceptor and chemoreceptor reflexes. Modulation of the chemoreceptor reflex by changes in baroreceptor activity. J. Clin. Invest. 53 (1974) 1226-1236
14. Hillege H.L., Girbes A.R., de Kam P.J., Boomsma F., de Zeeuw D., Charlesworth A., Hampton J.R., and van Veldhuisen D.J. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 102 (2000) 203-210
15. Hillege H.L., Nitsch D., Pfeffer M.A., Swedberg K., McMurray J.J., Yusuf S., Granger C.B., Michelson E.L., Ostergren J., Cornel J.H., de Zeeuw D., Pocock S., van Veldhuisen D.J., Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Investigators, and Candesartan in Heart Hailure: Assessment of Reduction in Mortality and Morbidity (CHARM) Investigators. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation 113 (2006) 671-678
16. Imai E., Horio M., Iseki K., Yamagata K., Watanabe T., Hara S., Ura N., Kiyohara Y., Hirakata H., Moriyama T., Ando Y., Nitta K., Inaguma D., Narita I., Iso H., Wakai K., Yasuda Y., Tsukamoto Y., Ito S., Makino H., Hishida A., and Matsuo S. Prevalence of chronic kidney disease (CKD) in the Japanese general population predicted by the MDRD equation modified by a Japanese coefficient. Clin. Exp. Nephrol. 11 (2007) 156-163
17. Imai E., Horio M., Nitta K., Yamagata K., Iseki K., Tsukamoto Y., Ito S., Makino H., Hishida A., and Matsuo S. Modification of the Modification of Diet in Renal Disease (MDRD) Study equation for Japan. Am. J. Kidney. Dis. 50 (2007) 927-937
18. Klein I.H., Ligtenberg G., Neumann J., Oey P.L., Koomans H.A., and Blankestijn P.J. Sympathetic nerve activity is inappropriately increased in chronic renal disease. J. Am. Soc. Nephrol. 14 (2003) 3239-3244
19. Levey A.S., Coresh J., Greene T., Stevens L.A., Zhang Y.L., Hendriksen S., Kusek J.W., Van Lente F., and Chronic Kidney Disease Epidemiology Collaboration. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann. Intern. Med. 145 (2006) 247-254
20. Matsukawa T., Sugiyama Y., Watanabe T., Kobayashi F., and Mano T. Gender difference in age-related changes in muscle sympathetic nerve activity in healthy subjects. Am. J. Physiol. 275 (1998) R1600-R1604
21. McAlister F.A., Ezekowitz J., Tonelli M., and Armstrong P.W. Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. Circulation 109 (2004) 1004-1009
22. Menon D.V., Arbique D., Wang Z., Adams-Huet B., Auchus R.J., and Vongpatanasin W. Differential effects of chlorthalidone versus spironolactone on muscle sympathetic nerve activity in hypertensive patients. J. Clin. Endocrinol. Metab. 94 (2009) 1361-1366
23. Oda Y., Asanoi H., Ueno H., Yamada K., Joho S., Kameyama T., Hirai T., Nozawa T., Takashima S., and Inoue H. Pulse-synchronous sympathetic burst power as a new index of sympathoexcitation in patients with heart failure. Am. J. Physiol. Heart Circ. Physiol. 287 (2004) H1821-H1827
24. Ronco C., Haapio M., House A.A., Anavekar N., and Bellomo R. Cardiorenal syndrome. J. Am. Coll. Cardiol. 52 (2008) 1527-1539
25. Sasayama S., Asanoi H., Ishizaka S., and Miyagi K. Evaluation of functional capacity of patients with congestive heart failure. In: Yasuda H., and Kawaguchi H. (Eds). New Aspects in the Treatment of Failing Heart (1992), Springer-Verlag, Tokyo 113-117
26. Soman S.S., Sandberg K.R., Borzak S., Hudson M.P., Yee J., and McCullough P.A. The independent association of renal dysfunction and arrhythmias in critically ill patients. Chest 122 (2002) 669-677
27. Wase A., Basit A., Nazir R., Jamal A., Shah S., Khan T., Mohiuddin I., White C., Saklayen M., and McCullough P.A. Impact of chronic kidney disease upon survival among implantable cardioverter-defibrillator recipients. J. Interv. Card. Electrophysiol. 11 (2004) 199-204
28. Ye S., Zhong H., Yanamadala V., and Campese V.M. Renal injury caused by intrarenal injection of phenol increases afferent and efferent renal sympathetic nerve activity. Am. J. Hypertens. 15 (2002) 717-724